ANPDF yields 2.91% · JNJ yields 2.13%● Live data
📍 ANPDF pulled ahead of the other in Year 1
Combined, ANPDF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ANPDF + JNJ for your $10,000?
ANTA Sports Products Limited, together with its subsidiaries, designs, develops, manufactures, and markets sporting footwear, apparel, and accessories worldwide. The company offers sportswear, including running, cross-training, basketball, soccer, boxing, winter sports, boxing, taekwondo, gymnastics, weightlifting, wrestling, outdoor sports, women's fitness, and skiing products, as well as sports fashion clothing, kid's sports fashion clothing and sportswear, and leisure footwear products under the FILA, FILA KIDS, FILA FUSION, KINGKOW, KOLON SPORT, SPRANDI, FILA FUSION, ANTA, DESCENTE, and ANTA KIDS brands. It also provides management, product design, logistics, and information technology services; manufactures shoe soles; holds trademarks; and develops and manages properties. As of December 31, 2021, it operated 9,403 ANTA stores; 2,054 FILA stores; 182 DESCENTE stores; and 152 KOLON SPORT stores. It also exports and imports sporting shoes. The company was founded in 1991 and is headquartered in Jinjiang, the People's Republic of China. ANTA Sports Products Limited is a subsidiary of Anta International Group Holdings Limited.
Full ANPDF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.